Trial · NCT05130047
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Fasting Serum C4 Levels | Aldafermin (NGM282) | 2.2 | Inter-Quartile Range 1.6 to 3.3 | ng/ML | |
| Fasting Serum C4 Levels | Placebo | 50.4 | Inter-Quartile Range 25.8 to 106.0 | ng/ML | |
| Change in Stool Consistency From Baseline to Day 28 | Aldafermin (NGM282) | -0.4 | Inter-Quartile Range -1.2 to 0.1 | score on a scale | |
| Change in Stool Consistency From Baseline to Day 28 | Placebo | -0.02 | Inter-Quartile Range -0.4 to 0.3 | score on a scale | |
| Stool Consistency | Aldafermin (NGM282) | Day 14 | 4.6 | Inter-Quartile Range 4.3 to 5.0 | score on a scale |
| Stool Consistency | Placebo | Day 14 | 4.8 | Inter-Quartile Range 4.0 to 5.3 | score on a scale |
| Stool Consistency | Aldafermin (NGM282) | Day 28 | 4.4 | Inter-Quartile Range 4.2 to 5.0 | score on a scale |
| Stool Consistency | Placebo | Day 28 | 5.1 | Inter-Quartile Range 4.4 to 5.5 | score on a scale |
| Abdominal Pain Score | Aldafermin (NGM282) | Baseline | 0.9 | Inter-Quartile Range 0.0 to 3.6 | score on a scale |
| Abdominal Pain Score | Placebo | Baseline | 0.4 | Inter-Quartile Range 0 to 1.0 | score on a scale |
| Abdominal Pain Score | Aldafermin (NGM282) | Day 28 | 0.6 | Inter-Quartile Range 0.0 to 1.3 | score on a scale |
| Abdominal Pain Score | Placebo | Day 28 | 0.5 | Inter-Quartile Range 0.1 to 1.1 | score on a scale |
| Bowel Movements | Aldafermin (NGM282) | Baseline | 2.3 | Inter-Quartile Range 1.9 to 3.2 | bowel movements per day |
| Bowel Movements | Placebo | Baseline | 2.3 | Inter-Quartile Range 1.8 to 3.0 | bowel movements per day |
| Bowel Movements | Aldafermin (NGM282) | Day 28 | 2.3 | Inter-Quartile Range 2.1 to 3.6 | bowel movements per day |
| Bowel Movements | Placebo | Day 28 | 2.1 | Inter-Quartile Range 1.7 to 2.7 | bowel movements per day |
| Proportion of Fecal Secretory (CDCA + DCA) Bile Acid as Measured in a Random Stool Sample by a Validated Laboratory Assay. | Aldafermin (NGM282) | Baseline | 63.8 | Inter-Quartile Range 58.3 to 66.7 | percentage of the total bile acids |
| Proportion of Fecal Secretory (CDCA + DCA) Bile Acid as Measured in a Random Stool Sample by a Validated Laboratory Assay. | Placebo | Baseline | 63.2 | Inter-Quartile Range 57.4 to 66.6 | percentage of the total bile acids |
| Proportion of Fecal Secretory (CDCA + DCA) Bile Acid as Measured in a Random Stool Sample by a Validated Laboratory Assay. | Aldafermin (NGM282) | Day 14 | 43.2 | Inter-Quartile Range 32.5 to 53.5 | percentage of the total bile acids |
| Proportion of Fecal Secretory (CDCA + DCA) Bile Acid as Measured in a Random Stool Sample by a Validated Laboratory Assay. | Placebo | Day 14 | 59.2 | Inter-Quartile Range 53.1 to 63.9 | percentage of the total bile acids |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05130047/results